Want to see TRAK full AI Analyst Report?
Top Page
ReposiTrak
(NYSE:TRAK)
Select Model
Select Model
Rating:75Outperform
Price Target:
$9.00
▲(14.65% Upside)
Action:Reiterated
Date:10/01/26
The score is driven primarily by strong financial quality (high margins, strong cash conversion, and an extremely low-debt balance sheet). The outlook from the earnings call is constructive, with management guiding to meaningful future contribution from touchless retailing and continued cost discipline, but technicals remain weak-to-neutral and the sharp revenue contraction flagged in the financial statement analysis is the main risk holding the score back.
Positive Factors
Recurring SaaS Growth
Recurring revenue growth improves the predictability of ReposiTrak’s business model and indicates continued adoption of its compliance platform. A larger subscription base can support steadier cash generation, deepen network participation, and provide a foundation for expanding modules and use cases.
Negative Factors
Uneven Revenue Performance
The fourth-quarter revenue decline shows that growth remains uneven despite stronger profitability. Revenue timing tied to traceability activity can make results less predictable, while repeated periods of weak top-line performance could limit operating leverage and reduce the resources available for sustained product expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring SaaS Growth
Recurring revenue growth improves the predictability of ReposiTrak’s business model and indicates continued adoption of its compliance platform. A larger subscription base can support steadier cash generation, deepen network participation, and provide a foundation for expanding modules and use cases.
Read all positive factors
ReposiTrak Key Performance Indicators (KPIs)
Any
Revenue by Type
Shows how sales split between recurring subscription fees, one‑time implementation or professional services, transaction or usage fees, and any hardware or license sales. A higher share of recurring subscription revenue signals more predictable cash flow, stronger margins, and easier long‑term growth for ReposiTrak, while a heavy reliance on one‑time services or transaction fees can make revenue lumpy and more sensitive to customer churn and slower new sales.
Shows how sales split between recurring subscription fees, one‑time implementation or professional services, transaction or usage fees, and any hardware or license sales. A higher share of recurring subscription revenue signals more predictable cash flow, stronger margins, and easier long‑term growth for ReposiTrak, while a heavy reliance on one‑time services or transaction fees can make revenue lumpy and more sensitive to customer churn and slower new sales.
Data provided by:
The Fly
The FlyReposiTrak (TRAK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$138.88M
Dividend Yield1.04%
Average Volume (3M)82.80K
Price to Earnings (P/E)18.9
Beta (1Y)1.35
Revenue Growth3.01%
EPS Growth12.00%
CountryUS
Employees67
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.41
Shares Outstanding18,201,204
10 Day Avg. Volume84,070
30 Day Avg. Volume82,799
Financial Highlights & Ratios
PEG Ratio1.58
Price to Book (P/B)3.14
Price to Sales (P/S)7.05
P/FCF Ratio20.00
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue5.87
Enterprise Value/Gross Profit6.91
Enterprise Value/Ebitda14.55
Forecast
1Y Price Target
$16.00Price Target Upside103.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.43
Revenue Forecast (FY)$26.00M
ReposiTrak Business Overview & Revenue Model
Company Description
ReposiTrak, Inc., a software-as-a-service provider, operates a business-to-business, e-commerce, compliance and traceability, and supply chain management platform in North America. It offers ReposiTrak Compliance Management, which reduces potentia...
How the Company Makes Money
ReposiTrak makes money primarily by selling access to its cloud-based compliance and supply-chain platform under recurring, subscription-style arrangements. A key revenue stream is fees paid for the use of its network/platform to collect, manage, ...
ReposiTrak Earnings Call Summary
Earnings Call Date:Sep 28, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Nov 16, 2026
Earnings Call Sentiment Positive
The call was strongly optimistic overall. The company reported higher full-year revenue, recurring revenue, operating margin, operating income, net income and diluted EPS, alongside lower operating expenses, substantial cash, no bank debt and continued capital returns. Management also expressed high confidence in the touchless retailing launch, the SPAR relationship and future traceability demand. The main negatives were the fourth-quarter revenue decline, the delayed traceability enforcement date, materially higher tax expense, modestly higher G&A costs and broader transportation and consumer-price pressures.Positive Updates
Full-Year Revenue and Recurring SaaS Growth
Fiscal 2026 total revenue increased 3% from $22.6 million to $23.3 million, while recurring revenue grew 4% as the company continued shifting its revenue mix toward predictable recurring SaaS revenue.
Negative Updates
Fourth-Quarter Revenue Decline
Fourth-quarter fiscal 2026 revenue declined 3% year-over-year to $5.6 million. Management attributed the comparison partly to an accelerated pace of traceability activity in the second half of the prior year as the FDA's original January 20, 2026 compliance date approached.
Read all updates
Q4-2026 Updates
Positive
Negative
Full-Year Revenue and Recurring SaaS Growth
Fiscal 2026 total revenue increased 3% from $22.6 million to $23.3 million, while recurring revenue grew 4% as the company continued shifting its revenue mix toward predictable recurring SaaS revenue.
Read all positive updates
Company Guidance
Management expects touchless retailing to generate “a little revenue in the current quarter that's coming up” and become “a very significant and meaningful contributor in 2027 and beyond,” with the offering expanding over the next fiscal year and “rapidly expand revenue”; management also expects traceability “by year-end” inbound inquiry rate and interest to increase, with a “meaningful impact” on the business in 2027, and expects traceability revenue to “grow more rapidly” as the July 20, 2028 FDA deadline approaches. The company’s current goal remains to redeem all remaining preferred shares “on or before December 2026,” subject to “business conditions, liquidity requirements and the Board's ongoing evaluation of our capital allocation priorities,” while continuing to return “approximately 50% of annual cash from operations” to shareholders; operating expenses are expected to remain “sub-$12 million” and enhancements to the software stack are expected to cause expenses to “not go up significantly.”ReposiTrak Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
84
Very Positive
| Breakdown | Jun 2026 | Jun 2025 | Sep 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.29M | 22.61M | 20.45M | 19.10M | 18.05M |
| Gross Profit | 19.98M | 18.92M | 17.04M | 15.79M | 14.86M |
| EBITDA | 8.49M | 9.02M | 7.61M | 7.11M | 5.38M |
| Net Income | 7.57M | 6.98M | 5.96M | 5.59M | 4.00M |
Balance Sheet | |||||
| Total Assets | 60.86M | 55.33M | 51.60M | 50.58M | 49.32M |
| Cash, Cash Equivalents and Short-Term Investments | 27.26M | 28.57M | 25.15M | 23.99M | 21.46M |
| Total Debt | 294.34K | 509.97K | 545.10K | 747.11K | 2.97M |
| Total Liabilities | 8.57M | 5.81M | 4.74M | 4.70M | 6.42M |
| Stockholders Equity | 52.29M | 49.52M | 46.85M | 45.88M | 42.90M |
Cash Flow | |||||
| Free Cash Flow | 8.21M | 8.40M | 6.89M | 7.96M | 6.05M |
| Operating Cash Flow | 8.22M | 8.42M | 6.96M | 8.86M | 6.10M |
| Investing Cash Flow | -4.12M | 169.00 | -100.71K | -903.19K | 1.32M |
| Financing Cash Flow | -5.42M | -5.01M | -5.70M | -5.43M | -10.03M |
ReposiTrak Technical Analysis
Negative
7.85
Price Trends
8.16
Negative
8.72
Negative
9.05
Negative
Market Momentum
-0.10
Positive
34.78
Neutral
16.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 7.85 is below the 20-day moving average (MA) of 8.12, below the 50-day MA of 8.16, and below the 200-day MA of 9.05, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 34.78 is Neutral, neither overbought nor oversold. The STOCH value of 16.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.
ReposiTrak Risk Analysis
ReposiTrak disclosed 26 risk factors in its most recent earnings report. ReposiTrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
ReposiTrak Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $138.88M | 18.85 | 14.94% | 1.04% | 3.01% | 12.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $289.18M | -48.63 | -12.79% | ― | 2.77% | 68.74% | |
57 Neutral | $365.09M | -19.62 | -3.92% | ― | 15.14% | 52.80% | |
48 Neutral | $41.57M | -2.43 | -41.63% | ― | 10.20% | 24.09% | |
47 Neutral | $22.52M | -7.74 | -26.38% | ― | -5.53% | -56.77% | |
45 Neutral | $447.93M | 25.79 | 3.57% | ― | ― | -19.23% |
* Technology Sector Average
TRAK
ReposiTrak
7.66
-6.65
-46.47%
AIOT
Powerfleet
2.69
-2.76
-50.64%
INLX
Intellinetics
4.96
-6.79
-57.79%
CMRC
Commerce.com
3.36
-1.31
-28.05%
CRGO
Freightos Limited
0.81
-2.78
-77.49%
ENRD
Einride AB Sponsored ADR
2.71
-8.09
-74.91%
ReposiTrak Corporate Events
Business Operations and StrategyStock BuybackDividendsFinancial DisclosuresPrivate Placements and Financing
ReposiTrak Posts Strong FY2026 Profitability and Cash Flow
Positive
Sep 30, 2026
ReposiTrak reported its financial results on September 28, 2026 for the fourth quarter and fiscal year ended June 30, 2026, highlighting modest top-line growth but stronger profitability and cash generation. Full-year revenue rose 3% to $23.3 mill...
Business Operations and StrategyExecutive/Board Changes
ReposiTrak Strengthens CFO Role with New Employment Agreement
Positive
Aug 18, 2026
On August 18, 2026, ReposiTrak, Inc. entered into a three-year Executive Employment Agreement with its Chief Financial Officer and Principal Accounting Officer, John R. Merrill, with automatic one-year renewals and an annual base salary of $325,00...
Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
ReposiTrak Expands Strategic Investment in SPAR Group
Positive
Jul 8, 2026
On July 1, 2026, ReposiTrak, Inc. entered into stock purchase agreements with William Bartels and WHB Services, Inc. Incentive Savings Plan and Trust to acquire 4,709,837 common shares of SPAR Group, Inc. for contingent consideration of about $3.3...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.